Ashwin Mohan News Today

In 2023, the Indian arm of the investment bank worked on deals like the blockbuster $365-million Tata Technologies IPO, the $630-million Cube Highways InvIT listing and the $280-million Brookfield India REIT QIP

Top investment bankers caught up with Moneycontrol for an incisive chat on the key capital market deal trends for 2024. Here are the edited excerpts from the interview

The city - sliced, diced and served with a dash of sauce

Mubadala has invested over $4 billion in India of which $1.6 billion has been deployed by the real estate and infrastructure investments platform.

At their meeting held on March 28, 2022,the Board of Directors of Aster DM Healthcare had constituted a Committee of Independent Directors of the Board to review the corporate structure of the company and explore options for enhancing value

IIHL or IndusInd International Holdings Ltd is one of the promoter entities of private sector lender IndusInd Bank and was the winning bidder for Reliance Capital under the IBC (insolvency and bankruptcy code) route.

Sehgal believes private equity interest will continue in the health insurance segment. In the financial services space, True North also backs NBFC FedFina and Fincare Small Finance Bank

Big investors have been consistently saying that they are moving their money out of frothy midcaps and smallcaps and shifting to largecaps

ChrysCapital has struck more than 100 deals in India, raised $5 billion over nine funds and returned $6.5 billion to investors. The leading private equity firm backs companies ranging from Lenskart and Bandhan MF to Mankind Pharma and GMM Pfaudler

The Sun Pharma founder says it for his children, Aalok and Vidhi, to decide if they want to be owner-managers, working managers or adopt a hands-off approach